Dyne Therapeutics, Inc.
DYNCIK 0001818794 · last filing Jul 8, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
0 bought / 777,451 sold
net −777,451 sh · −$17.86M
- buys
- 0
- sells
- 10
- insiders active
- 1
Filing tape
Filed Wed, Jul 8, 2026
- −777,451 sh · $17.86M
Rhodes Jason P — Director
- Sold253,039Common Stock@ $22.79→ 4,223,448 held
- Sold127,182Common Stock@ $22.79→ 1,217,537 held
- Sold100,019Common Stock@ $22.79→ 875,912 held
- Sold124,379Common Stock@ $23.17→ 4,099,069 held
- Sold29,587Common Stock@ $23.62→ 4,069,482 held
- Sold62,543Common Stock@ $23.17→ 1,154,994 held
- Sold14,844Common Stock@ $23.62→ 1,140,150 held
- Sold49,193Common Stock@ $23.17→ 826,719 held
- Sold11,665Common Stock@ $23.62→ 815,054 held
- Sold5,000Common Stock@ $23.61→ 2,962 held
Insiders on this tape
- Rhodes Jason PDirector
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.